A prospective observational study of oral abrocitinib and narrow-band UVB in refractory progressive vitiligo JAAD Supplementary Figures

Published: 4 June 2024| Version 1 | DOI: 10.17632/tg4wjy5bj6.1
Contributor:
Zhongyi Xu

Description

Supplementary Figures

Files

Institutions

Huashan Hospital Fudan University

Categories

Vitiligo, Janus Kinase

Licence